Post-earnings recap
Reported
Tue, Feb 27, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Rad Laboratories reported a strong EPS performance, exceeding expectations significantly. However, the stock reacted negatively, dropping 1.49% on the day. The lack of revenue guidance may have contributed to investor caution, despite the positive EPS surprise.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.32 | N/A | +87.70% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the strong EPS results, highlighting their commitment to growth. However, they did not provide specific revenue guidance.
We are pleased with our EPS performance this quarter.
While we did not provide revenue guidance, we remain focused on our long-term growth strategy.